Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nella Bieszk, Michael Grabner, Wenhui Wei, Nicole G Bonine & Judith J Stephenson. (2016) The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targets. Risk Management and Healthcare Policy 9, pages 243-251.
Read now
Read now
Charles Shaefer, Debbie Hinnen & Christopher Sadler. (2016) Hypoglycemia and diabetes: increased need for awareness. Current Medical Research and Opinion 32:9, pages 1479-1486.
Read now
Read now
Andres Digenio, Sudeep Karve, Sean D. Candrilli & Mehul Dalal. (2014) Prandial Insulin versus Glucagon-Like Peptide-1 Added to Basal Insulin: Comparative Effectiveness in the Community Practice Setting. Postgraduate Medicine 126:6, pages 49-59.
Read now
Read now
Articles from other publishers (14)
Hamid Ashraf, Ahmad Faraz, Jamal Ahmad & Ghazala Kohkan. (2021) Achievement of guideline targets of glycemic and non-glycemic parameters in North Indian type 2 diabetes mellitus patients: A retrospective analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:1, pages 425-431.
Crossref
Crossref
Kathryn M. Harmes, Elizabeth Shih, Melissa Plegue, Cameron Shultz & Heidi L. Diez. (2019) Family physician perceptions of the role and value of the clinical pharmacist in the management of patients with type 2 diabetes. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 3:1, pages 15-20.
Crossref
Crossref
Dennis Bruemmer & Steven E. Nissen. (2020) Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities. Cardiovascular Endocrinology & Metabolism 9:3, pages 81-89.
Crossref
Crossref
Josep Franch-Nadal, Fermín García-Gollarte, Alfonso Pérez del Molino, María L. Orera-Peña, Marta Rodríguez de Miguel, Malena Melogno-Klinkas, Héctor D. de Paz, Susana Aceituno & Patricia Rodríguez-Fortúnez. (2018) Physicians’ and Pharmacists’ Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study. Clinical Drug Investigation 39:1, pages 73-84.
Crossref
Crossref
Jonathan Colasanti, Karla I Galaviz, C Christina Mehta, Kartika Palar, Michael F Schneider, Phyllis Tien, Adaora A Adimora, Maria Alcaide, Mardge H Cohen, Deborah Gustafson, Roksana Karim, Daniel Merenstein, Anjali Sharma, Gina Wingood, Vincent C Marconi, Ighovwerha Ofotokun & Mohammed K Ali. (2018) Room for Improvement: The HIV–Diabetes Care Continuum Over 15 Years in the Women’s Interagency HIV Study. Open Forum Infectious Diseases 5:6.
Crossref
Crossref
Lawrence Blonde, Pablo Aschner, Clifford Bailey, Linong Ji, Lawrence A Leiter & Stephan Matthaei. (2017) Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes and Vascular Disease Research 14:3, pages 172-183.
Crossref
Crossref
Beatriz H. Carlini, Sharon B. Garrett & Gregory T. Carter. (2016) Medicinal Cannabis. American Journal of Hospice and Palliative Medicine® 34:1, pages 85-91.
Crossref
Crossref
Neesha RamchandaniKim JohnsonKaren CullenTerri HammJean BisordiSusan Sullivan-Bolyai. (2016) CDE Perspectives of Providing New-Onset Type 1 Diabetes Education Using Formal Vignettes and Simulation. The Diabetes Educator 43:1, pages 97-104.
Crossref
Crossref
Alexander Berezin. (2016) Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:2, pages S176-S183.
Crossref
Crossref
Erin Rayner‐Hartley & Tara Sedlak. (2016) Ranolazine: A Contemporary Review. Journal of the American Heart Association 5:3.
Crossref
Crossref
Thiruvinvamalai S. Dharmarajan, Dheeraj Mahajan, Annie Zambrano, Bikash Agarwal, Rachel Fischer, Zahra Sheikh, Anna Skokowska-Lebelt, Meenakshi Patel, Rebecca Wester, Naga P. Madireddy, Naushira Pandya, Florence T. Baralatei, Jackie Vance & Edward P. Norkus. (2016) Sliding Scale Insulin vs Basal-Bolus Insulin Therapy in Long-Term Care: A 21-Day Randomized Controlled Trial Comparing Efficacy, Safety and Feasibility. Journal of the American Medical Directors Association 17:3, pages 206-213.
Crossref
Crossref
Robert H. Eckel, Robert R. Henry, Patrick Yue, Arvinder Dhalla, Pamela Wong, Philip Jochelson, Luiz Belardinelli & Jay S. Skyler. (2015) Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes. Diabetes Care 38:7, pages 1189-1196.
Crossref
Crossref
Martin M. Grajower. (2015) Adding Rapid-Acting Insulin or Glp-1 Receptor Agonist to Basal Insulin: Penny Wise and Pound Foolish?. Endocrine Practice 21:1, pages 88-90.
Crossref
Crossref
Mehul R. Dalal, Lin Xie, Onur Baser & Andres DiGenio. (2015) Adding Rapid-Acting Insulin or Glp-1 Receptor Agonist to Basal Insulin: Outcomes in A Community Setting. Endocrine Practice 21:1, pages 68-76.
Crossref
Crossref